
|Articles|June 1, 2004
Genetic marker method for diabetic retinopathy wins patent
Waltham, MA-Interleukin Genetics Inc. has received a U.S. patent for a method that uses specific genetic markers to identify people with diabetes who are at an increased risk of retinopathy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Sight Sciences reports new data supporting long-term efficacy of OMNI Surgical System
2
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
3
Retina experts reflect on how OCT transformed patient care
4
AAO 2025: 12-month outcomes of travoprost intracameral implant (iDose TR) in conjunction with cataract surgery
5



















































.png)


